Malignant deep brain stimulation-withdrawal syndrome in a patient with Parkinson's disease

Movement Disorders

Volumn 28, Issue 12, 2013, Pages 1640-1641

  Neuneier, Janina ^a   Barbe, Michael T ^a,b   Dohmen, Christian ^a   Maarouf, Mohammad ^a   Wirths, Jochen ^a   Fink, Gereon R ^a,b   Timmermann, Lars ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; C REACTIVE PROTEIN; DIPYRONE; LEVODOPA; PARACETAMOL; PIPERACILLIN PLUS TAZOBACTAM; PROCALCITONIN; THIAMAZOLE;

AGED; ARTICLE; BODY TEMPERATURE; BRAIN DEPTH STIMULATION; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; DISSEMINATED INTRAVASCULAR CLOTTING; DISSEMINATED INTRAVASCULAR COAGULATION MARKER; ELECTRODE; ERYSIPELAS; ESSENTIAL HYPERTENSION; FLUID RESUSCITATION; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERTHERMIA; INTENSIVE CARE; ISCHEMIC HEART DISEASE; MALE; MULTIPLE ORGAN FAILURE; PARKINSON DISEASE; PRIORITY JOURNAL; RESEARCH; SKIN INFECTION; STEREOTACTIC PROCEDURE; SUBTHALAMIC NUCLEUS; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE; WITHDRAWAL SYNDROME;

AGED; DEEP BRAIN STIMULATION; FATAL OUTCOME; FEVER; HUMANS; MALE; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 84886389165     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25494     Document Type: Article

References (8)

1. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009;8:67-81.
2. Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010;25:578-586.
3. Castrioto A, Lozano AM, Poon Y-Y, Lang AE, Fallis M, Moro E. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 2011;68:1550-1556.
4. Umemura A, Oka Y, Yamamoto K, Okita K, Matsukawa N, Yamada K. Complications of subthalamic nucleus stimulation in Parkinson's disease. Neurol Med Chir (Tokyo) 2011;51:749-755.
5. Anheim M, Fraix V, Chabardes S, Krack P, Benabid AL, Pollak P. Lifetime of Itrel II pulse generators for subthalamic nucleus stimulation in Parkinson's disease. Mov Disord 2007;22:2436-2439.
6. Hariz MI, Johansson F. Hardware failure in parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency. Mov Disord 2001;16:166-168.
7. Douglas A, Morris J. It was not just a heatwave! Neuroleptic malignant-like syndrome in a patient with Parkinson's disease. Age Ageing 2006;35:640-641.
8. Mizuno Y, Takubo H, Mizuta E, Kuno S. Malignant syndrome in Parkinson's disease: concept and review of the literature. Parkinsonism Relat Disord 2003;9(suppl 1):S3-S9.